CHEBI:170006 - α-Neup5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GlcpNAc-(1→2)-α-D-Manp

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-Neup5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GlcpNAc-(1→2)-α-D-Manp
ChEBI ID CHEBI:170006
ChEBI ASCII Name alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp
Definition An amino tetrasaccharide comprising α-N-acetylneuraminyl, β-D-galactosyl, N-acetyl-β-D-glucosaminyl and α-D-mannose residues linked sequentially (2→3), (1→3) and (1→2).
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C31H52N2O24
Net Charge 0
Average Mass 836.747
Monoisotopic Mass 836.29100
InChI InChI=1S/C31H52N2O24/c1-8(38)32-15-10(40)3-31(30(49)50,56-24(15)17(42)11(41)4-34)57-25-20(45)14(7-37)53-29(22(25)47)54-23-16(33-9(2)39)28(52-13(6-36)19(23)44)55-26-21(46)18(43)12(5-35)51-27(26)48/h10-29,34-37,40-48H,3-7H2,1-2H3,(H,32,38)(H,33,39)(H,49,50)/t10-,11+,12+,13+,14+,15+,16+,17+,18+,19+,20-,21-,22+,23+,24+,25-,26-,27-,28-,29-,31-/m0/s1
InChIKey VNXPJJCXGFZPHP-ULOAPSLMSA-N
SMILES [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]3O)[C@@H]2NC(C)=O)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO
ChEBI Ontology
Outgoing α-Neup5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GlcpNAc-(1→2)-α-D-Manp (CHEBI:170006) is a amino tetrasaccharide (CHEBI:59412)
α-Neup5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GlcpNAc-(1→2)-α-D-Manp (CHEBI:170006) is a glucosamine oligosaccharide (CHEBI:22485)
IUPAC Name
5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranose
Synonyms Sources
α-Neu5Ac-(2→3)-β-D-Gal-(1→3)-β-D-GlcNAc-(1→2)-α-D-Man ChEBI
N-acetyl-α-neuraminyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannose ChEBI
Neu5Aca2-3Galb1-3GlcNAcb1-2Mana ChEBI
Neu5Acα2-3Galβ1-3GlcNAcβ1-2Manα IUPAC
Citation Waiting for Citations Type Source
31537530 PubMed citation Europe PMC
Last Modified
26 April 2021